These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19348328)

  • 1. [Effect of surfactant administration time on the outcomes in low and extremely low birth weight neonates].
    Mostovoĭ AV; Aleksandrovich IuS; Sapun OI; Trifonova EG; Tret'iakova EP; Bogdanova RZ; Karpova AL
    Anesteziol Reanimatol; 2009; (1):43-6. PubMed ID: 19348328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
    Ghaemi S; Mohamadymasodi M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect from surfactant therapy in extremely low birth weight infants depending on the method of delivery].
    Iarŭkova N; Nikolov A; Slŭncheva B; Vakrilova L; Pramatarova T; Dimitrov A
    Akush Ginekol (Sofiia); 2007; 46(3):31-5. PubMed ID: 18018780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
    Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary surfactant deficiencies in extremely low birth weight premature infants].
    Rivera S; Gaugler C; Langlet C; Villega F; Astruc D; Escande B; Kuhn P; Messer J
    Arch Pediatr; 2004 Nov; 11(11):1346-50. PubMed ID: 15519835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of neonatal respiratory distress syndrome with surfactant BL].
    Zatovka GN; Duginova SA; Safarov AA; Nechaeva MV; Blauberg EN
    Anesteziol Reanimatol; 2006; (1):38-43. PubMed ID: 16613043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary surfactant administration in neonates with respiratory decompensation.
    Bissinger R; Carlson C; Michel Y; Dooley C; Hulsey T; Jenkins D
    J Perinatol; 2008 Mar; 28(3):192-8. PubMed ID: 18235534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of surfactant replacement trials.
    Suresh GK; Soll RF
    J Perinatol; 2005 May; 25 Suppl 2():S40-4. PubMed ID: 15861172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovations in cardiopulmonary care of the low-birth-weight infant.
    Cusson RM
    NAACOGS Clin Issu Perinat Womens Health Nurs; 1992; 3(1):62-74. PubMed ID: 1562447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved growth and decreased morbidities in <1000 g neonates after early management changes.
    Geary CA; Fonseca RA; Caskey MA; Malloy MH
    J Perinatol; 2008 May; 28(5):347-53. PubMed ID: 18337743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal and infant care and outcomes.
    Little GA
    Curr Opin Obstet Gynecol; 1992 Feb; 4(1):55-60. PubMed ID: 1543831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective surfactant prophylaxis in preterm infants born at < or =31 weeks' gestation using the stable microbubble test in gastric aspirates.
    Fiori HH; Fritscher CC; Fiori RM
    J Perinat Med; 2006; 34(1):66-70. PubMed ID: 16489887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasopharyngeal surfactant administration to prevent neonatal respiratory distress syndrome.
    Fernandes CJ; Horst DA; O'Donovan DJ
    J Perinatol; 2005 May; 25(5):361-2; author reply 363. PubMed ID: 15861205
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion.
    Whyte RK; Kirpalani H; Asztalos EV; Andersen C; Blajchman M; Heddle N; LaCorte M; Robertson CM; Clarke MC; Vincer MJ; Doyle LW; Roberts RS;
    Pediatrics; 2009 Jan; 123(1):207-13. PubMed ID: 19117884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
    Wirbelauer J; Speer CP
    J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Academy of Pediatrics Committee on Fetus and Newborn: Surfactant replacement therapy for respiratory distress syndrome.
    Pediatrics; 1991 Jun; 87(6):946-7. PubMed ID: 2034505
    [No Abstract]   [Full Text] [Related]  

  • 18. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does the combination of primary high-frequency oscillation ventilation and prophylactic surfactant therapy improve the prognosis for extremely low birth weight infants?].
    Kribs A; Devenge J; Hünseler C; Roth B
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):190-6. PubMed ID: 15508053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined use of pulmonary surfactants with continuous distending pressure is useful in the treatment of respiratory distress syndrome in very low birth weight infants].
    Liu CJ; Yang ZY; Chen Z; Shao XH
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):451-4. PubMed ID: 18706159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.